Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04821401 · ClinicalTrials.gov registry record · NA

Rejuvant™ Safety and Biomarker Study

A NA study of Aging Well, sponsored by Ponce De Leon Health.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04821401 is a NA study of Aging Well that has completed, run by Ponce De Leon Health. The registered enrollment target is 100 participants, above the 57-participant average among 7 other Aging Well trials with a reported enrollment target (75% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04821401, a NA study of Aging Well, has completed, sponsored by Ponce De Leon Health.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

In this randomized, double-blind, placebo-controlled trial in adult men ages 45-65 years and postmenopausal women to age 75 years, the anti-inflammatory property of proprietary CaAKG based dietary supplements will be assessed by the measurement of C-reactive protein (CRP) as the primary endpoint. Secondary safety endpoints will be assessed by monitoring blood chemistry results and recorded adverse effects. In addition, the biological age of the participants will be determined by the level of DNA methylation measured from saliva samples. An open label Sub-Study was conducted on eligible and consenting subjects who were assigned to the placebo. Assessments and endpoints remained the same as for the main study.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Rejuvant

Study Locations (1)

Indiana

  • Indiana University School of Medicine - Indianapolis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-02-07
Est. Completion 2022-02-14
Phase NA

Sponsor

Ponce De Leon Health

1 total trials

What the Registry Record Tells You About NCT04821401

The ClinicalTrials.gov registry entry for NCT04821401 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 57-participant average among 7 other Aging Well trials with a reported enrollment target (75% higher). The listed sponsor is Ponce De Leon Health, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging Well appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04821401 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT04821401 about?

NCT04821401 is a clinical study titled "Rejuvant™ Safety and Biomarker Study". In this randomized, double-blind, placebo-controlled trial in adult men ages 45-65 years and postmenopausal women to age 75 years, the anti-inflammatory property of proprietary CaAKG based dietary supplements will be assessed by the measurement of C-reactive protein (CRP) as the primary endpoint. Se...

What is the current status of trial NCT04821401?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-02-07. Estimated completion is 2022-02-14.

What conditions does trial NCT04821401 study?

This clinical trial studies the following conditions: Aging Well.

What interventions are being tested in trial NCT04821401?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Rejuvant (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04821401?

This trial is sponsored by Ponce De Leon Health, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04821401 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging Well

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.